JPRN-UMIN000007912已完成未知
Telaprevir therapy in Japanese patients infected with HCV - Teraprevir in Japanese CH-C
Chiba University, Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2012年5月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hemoglobin <12g/dl, Neutrophil < 1500/mm3, or Platelet count <100000/mm3 2) Drug allergy to telaprevir, interferon, ribavirin or nucleoside analogues 3) Past-history of dermatological reaction of teraprevir 4) Pregnant women, etc. 5) Women cannot prevent conception. 6) Men cannot prevent conception. 7) Severe heart diseases 8) Abnormal hemoglobinemia 9) Severe renal dysfunction 10) Uncontrolable mental illness 11) Severe liver diseases 12) Uncontrolable autoimmune diseases 13) Past-history of hypersensitivity against vaccination, etc. 14) Patients take prohibited drugs, which interacts with telaprevir. 15) Doctors judged patients as inappropriate persons in this trial
研究者
相似试验
招募中
Unknown
Efficacy and safety of Sofosbuvir and Velpatasvir for Japanese patients with HCV related hepatitis in real-world settingJPRN-UMIN000050842Hokkaido University Hospital60
进行中（未招募）
不适用
Study about human defence for chronic hepatitis C in patients who will be treated with telaprevir with peginterferon-alfa and ribaviriEUCTR2011-005636-26-NLFoundation for Liver Research25
已完成
不适用
Effect of Telaprevir in triple therapy for chronic hepatitis C patients on Intrahepatic immunological Mechanisms1001965410047438Hepatitis CNL-OMON39260Stichting Maag-, Darm- en Leveronderzoek25
已完成
不适用
Virological efficacy and safety of telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosisChronic hepatitis CJPRN-UMIN000011105The Kyushu University Liver Disease Study (KULDS) Group150
已完成
不适用
The Effect of telaprevir-based triple therapy for chronic hepatitis C patients on gastric emptyingJPRN-UMIN000012279Chiba University30